Bacomind – Clinical Proven Cognition Enhancer for Elder and Children

Clinical Studies of Bacomind in older persons

Efficacy and tolerability of

on memory improvement in older persons -A double blind placebo controlled study.

Subjects recruited: 65 elderly individuals (age group between 50-75 years).

Dose: Daily one capsule containing 450 mg of

or placebo.

Duration: 24 weeks.

Results:
The study findings suggested that

has positive effect on cognitive process such as attention, short term and long term memory components.

also helped in improving the long term component of verbal memory as well as visual memory in elderly individuals.

Efficacy study of

on memory improvement in Children requiring Individual Education Programme [IEP].

Subjects recruited: 28 children (age group between 4-18 years).

Dose: Daily one capsule containing 225 mg of

or placebo.

Duration: 4 months.

Results:
The

showed significant improvement in the working memory, logical memory, in memory related to personal life and also visual as well as auditory memory in children requiring IEP.

Efficacy of

in improving memory in healthy Australians over the age of 55 years - A 12 week randomized, double blind, placebo-controlled, parallel group clinical trial.

Subjects recruited: 81 healthy older Australians over the age of 55 years (age group between 55-86 years).

Dose: Daily one tablet containing 300 mg of or placebo.

Duration: 12 weeks.

Results:
significantly improved memory acquisition and retention in older Australians.